1999 | Synthesis of L-sangivamycin and toyocamycin analogues and their inhibitory activities of Ser/Thr protein kinases | 정낙신 | Conference Paper |
2007 | Synthesis of N6-Substituted 3′-ureidoadenosine derivatives as highly potent agonists at the mutant A3 adenosine receptor | 정낙신 | Conference Paper |
2009 | Synthesis of neplanocin a analog with 2′′-"up"-C-methyl substituent as potential anti-HCV Agent | 정낙신 | Article |
2002 | Synthesis of novel (2R,4R)- and (2S,4S)-iso dideoxynucleosides with exocyclic methylene as potential antiviral agents | 정낙신 | Article |
2005 | Synthesis of novel apio carbocyclic nucleoside analogues as selective A3 adenosine receptor agonists | 이강만; 정낙신 | Article |
2002 | Synthesis of novel D-2′-Deoxy-2′-C-difluoromethylene-4′-thiocytidine as a potential antitumor agent | 정낙신 | Article |
2006 | Synthesis of novel l-N-MCd4T as a potent anti-HIV agent | 정낙신 | Article |
2023 | Synthesis of oligonucleotides containing 5′-homo-4′-selenouridine derivative and its increased resistance against nuclease | 유진하 | Article |
2006 | The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor-positive and estrogen receptor-negative human breast cancers | 정낙신 | Article |
2012 | The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth | 정낙신 | Article |
2013 | Thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells | 정낙신 | Article |
1998 | Total synthesis of (±)-Iso-d4T as potential antiviral agent | 정낙신 | Article |
2009 | Truncated fluorocyclopentenyl pyrimidines as S-adenosylhomocysteine hydrolase inhibitors | 이강만; 정낙신; 최원준 | Article |
1996 | Use of a cyclic sulfite as an epoxide surrogate in the regioselective synthesis of a carbocyclic ring-enlarged 4′,1'a-methano oxetanocin analogue | 정낙신 | Article |
2011 | X-ray crystal structure and binding mode analysis of human S-adenosylhomocysteine hydrolase complexed with novel mechanism-based inhibitors, haloneplanocin A analogues | 이강만; 정낙신; 최선; 최원준 | Article |